Source: Annual Congress 2013 –COPD biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Singh, A. Mackay, A. Patel, B. Kowlessar, D. Garcha, S. Brill, R. Sapsford, L. Donnelly, P. Barnes, G. Donaldson, J. Wedzicha (London, United Kingdom). Concordance between airway inflammation and health status in COPD patients with bacterial colonisation. Eur Respir J 2013; 42: Suppl. 57, 2172

Member's Comments

No comment yet.

Related content which might interest you: Clinical characteristics and health status of spontaneous sputum producers in COPD Source: International Congress 2015 – Best abstracts in chronic care Year: 2015 Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD Source: Eur Respir J 2004; 23: 685-691 Year: 2004 Impaired health status in primary care COPD patients is underestimated Source: International Congress 2015 – Respiratory disease management in primary care Year: 2015 The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases Source: International Congress 2014 – Markers Year: 2014 The pulmonary artery-aorta ratio, exacerbation rate and quality of life in stable COPD patients Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Longitudinal changes in COPD patients in primary care Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 Impact on patients' health status following early identification of a COPD exacerbation Source: Eur Respir J 2007; 30: 907-913 Year: 2007 Impact of preventing exacerbations on deterioration of health status in COPD Source: Eur Respir J 2004; 23: 698-702 Year: 2004 One-year change in health status and outcomes in chronic obstructive pulmonary disease Source: International Congress 2014 – Best abstracts in chronic care Year: 2014 Assessment of quality of life of bronchiectasis patients associated with asthma and COPD. Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases Year: 2019 Impact of lung function impairment and exacerbation history on COPD patient-reported utility Source: International Congress 2014 – COPD markers Year: 2014 The impact of exacerbations on adherence and outcomes of pulmonary rehabilitation in patients with COPD Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases Year: 2016 Loneliness and lack of social support severely influences patients’ quality of life. Secondary findings from our focusgroup study in asthma and COPD patients Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 Quality of life in obstructive lung diseases Source: Annual Congress 2013 –Various issues in clinical respiratory physiology Year: 2013 Experiences of well-being when living with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Qualitative and quantitative research that contributes to respiratory nursing practice Year: 2014 Fatigue and decreased health can predict mortality in COPD Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Is anxiety and depression a barrier to enrolment in a study in chronic obstructive pulmonary disease (COPD)? Source: International Congress 2016 – Kaleidoscope of respiratory nursing Year: 2016 Reduction in clinically important deterioration in COPD with aclidinium/formoterol Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 The association between objective CT measures of bronchiectasis and health-related quality of life in COPD Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Predictors of respiratory health status in patients with severe asthma Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life Year: 2016